TITLE

Atovaquone-Proguanil versus Chloroquine-Proguanil for Malaria Prophylaxis in Nonimmune Pediatric Travelers: Results of an International, Randomized, Open-Label Study

AUTHOR(S)
Camus, Daniel; Djossou, Félix; Schilthuis, Herbert J.; Høgh, Birthe; Dutoit, Emmanuel; Malvy, Denis; Roskell, Neil S.; Hedgley, Corinne; De Boever, Erika H.; Miller, Gerri B.
PUB. DATE
June 2004
SOURCE
Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1716
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Atovaquone-proguanil has been shown to be effective and well tolerated for malaria prophylaxis in residents of countries of endemicity and in nonimmune adult travelers, but data about traveling children are limited. In a randomized, open-label, multicenter prophylaxis trial, 221 nonimmune pediatric travelers (age, 2-17 years) received either atovaquone-proguanil or chloroquine-proguanil. Safety and clinical outcome were evaluated 7, 28, and 60 days after travel. By posttravel day 7, a total of 39 (35%) of 110 atovaquone-proguanil and 41 (37%) of 111 chloroquine-proguanil recipients reported ⩾1 adverse event. The data indicate that, over the course of treatment, fewer atovaquone-proguanil recipients had treatment-related adverse events (8% vs. 14%), including gastrointestinal complaints (5% vs. 10%). Two subjects discontinued prophylaxis because of drug-related adverse events; both had received chloroquine-proguanil. Observed compliance with prophylaxis was similar before and during travel, but it was higher for atovaquone-proguanil in the posttravel period. No study participant developed malaria. Atovaquone-proguanil was well tolerated and is an important addition to the limited arsenal of prophylactic agents available to children.
ACCESSION #
13282056

 

Related Articles

  • Malaria prophylaxis.  // Pulse;4/26/2004, Vol. 64 Issue 17, p77 

    Presents information on malaria prophylaxis. Recommended regimens and alternative regimens for travelers to certain countries; Children's doses of antimalarial prophylactics; Children's doses of prophylactic Malarone.

  • Finding parasites and finding challenges: improved diagnostic access and trends in reported malaria and anti-malarial drug use in Livingstone district, Zambia. Masaninga, Freddie; Sekeseke-Chinyama, Masela; Malambo, Thindo; Moonga, Hawela; Babaniyi, Olusegun; Counihan, Helen; Bell, David // Malaria Journal;2012, Vol. 11 Issue 1, p341 

    Background: Understanding the impact of malaria rapid diagnostic test (RDT) use on management of acute febrile disease at a community level, and on the consumption of anti-malarial medicines, is critical to the planning and success of scale-up to universal parasite-based diagnosis by health...

  • Malaria prophylaxis.  // Pulse;6/3/2002, Vol. 62 Issue 22, p92 

    Provides information on malaria prophylaxis. Ways to avoid malaria; List of travel destinations where immunization for malaria prophylaxis is recommended; Recommended regimens; Alternative regimens; Doses of antimalarial prophylactics that are required for children.

  • GI SNAPSHOT. J. M.Levsky, L. A.; Farkas, D. T.; Narula, A. // Gut;Dec2003, Vol. 52 Issue 12, p1727 

    A 41 year old Hispanic man with no significant medical history presented with a two month history of fever, chills, and night sweats. He denied nausea, vomiting, diarrhea, weight loss, cough, and dysuria. On examination he was in no acute distress, with a temperature of 38.2°C and normal...

  • Preventing malaria in travellers. Lalloo, David G.; Hill, David R. // BMJ: British Medical Journal (International Edition);6/14/2008, Vol. 336 Issue 7657, p1362 

    The article presents an overview of steps physicians can take to prevent malaria in international travelers, which include the ABCD approach to prevention. A discussion of the ABCD approach to prevention, which includes the awareness of risk, bite avoidance, compliance with chemoprophylaxis and...

  • fighting the parasite from hell. Dunavan, Claire Panosian // Discover;Aug2005, Vol. 26 Issue 8, p48 

    Explains the health risks of malaria. Description of the malaria pathogen; Estimated economic losses attributable to malaria in Africa; Sightings of chloroquine-resistant parasites. INSETS: QUININE, VIPER'S BROTH, AND LIVE SPIDERS;GOOD GENES CAN HELP.

  • Paludrine.  // Royal Society of Medicine: Medicines;2002, p421 

    The article presents information on Paludrine, a proprietary, non-prescription preparation of the antimalarial proguanil hydrochloride. It can be used in the prevention of malaria, and is available as tablets.

  • Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in amazon basin communities. Santelli, Ana C; Ribeiro, Isabella; Daher, Andr�; Boulos, Marcos; Marchesini, Paola B; dos Santos, Roseli La Corte; Lucerna, Marize BF; Magalhães, Izanelda; Leon, Antonio P; Junger, Washington; Ladislau, José LB // Malaria Journal;2012, Vol. 11 Issue 1, p286 

    Background: Studies in South-East Asia have suggested that early diagnosis and treatment with artesunate (AS) and mefloquine (MQ) combination therapy may reduce the transmission of Plasmodium falciparum malaria and the progression of MQ resistance. Methods: The effectiveness of a fixed-dose...

  • Impact of community-based presumptive chloroquine treatment of fever cases on malaria morbidity and mortality in a tribal area in Orissa State, India. Das, Lalit K.; Jambulingam, Purushothaman; Sadanandane, Candasamy // Malaria Journal;2008, Vol. 7, Special section p1 

    Background: In the Global Strategy for Malaria Control, one of the basic elements is early detection and prompt treatment of malaria cases, especially in areas where health care facilities are inadequate. Establishing or reviving the existing drug distribution centers (DDC) at the peripheral...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics